Clinical Trials Browser

Interventional × Breast Neoplasms × pepinemab × Clear all

NCT05378464 2026-04-01

Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer

Phase 1 Recruiting

Breast Neoplasms